Global Glucoamylase

Glucoamylase Comprehensive Study by Type (Solid State Fermentation, Liquid State Fermentation), Application (Dairy Products, Personal Care, Alcohol Production, Others), Source (Microorganisms (Yeast, Fungi, Bacteria), Plants (Rice, Wheat, Corn, Others), Others), End User (Pharmaceuticals & Healthcare, Food & Beverages, Textile, Paper, Others) Players and Region - Global Market Outlook to 2030

Glucoamylase Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Glucoamylase
Glucoamylase is an enzyme that breaks down starch, a complex carbohydrate, into glucose, a simple sugar. It is found in a variety of microorganisms, including bacteria, fungi, and yeast. Glucoamylase is used in several industrial applications, including the production of food and beverages, biofuels, and pharmaceuticals. Glucoamylase is a widely used biocatalyst in the food industry. The major application of glucoamylase is the catalysis of alcohol, starch sugar, beer, white spirit, and other fermentation industries. The glucoamylase market is poised for continued growth in the coming years, driven by the increasing demand for biofuels, food and beverage products, and low-calorie sweeteners. By addressing the challenges and capitalizing on the opportunities, manufacturers can position themselves for success in this dynamic market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.0%


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. There are various growth opportunities in this market which are captured by leading players via tracking the ongoing process enhancement and huge investment in market growth strategies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Glucoamylase market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Novozymes A/S (Denmark), DuPont (United States), AB Enzymes (Denmark), Kerry Group plc. (Ireland), Cargill, Incorporated. (United States), ADM (United States), Tate & Lyle (United Kingdom), Südzucker AG (Germany), Roquette Frères (France) and Bio-Cat, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Guangxi Jinyuan Biochemical Group Co., Ltd. (China), VTR BIOTECH PTY LIMITED (Austria), DSM (Netherlands), Wuhan Sunhy Biology Co., Ltd. (China) and Beijing Challenge International Trade Co., Ltd. (China).

Segmentation Overview
AMA Research has segmented the market of Global Glucoamylase market by Type (Solid State Fermentation and Liquid State Fermentation), Application (Dairy Products, Personal Care, Alcohol Production and Others) and Region.



On the basis of geography, the market of Glucoamylase has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Source, the sub-segment i.e. Microorganisms (Yeast, Fungi, Bacteria) will boost the Glucoamylase market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceuticals & Healthcare will boost the Glucoamylase market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Demand for Gluten-Free Products

Market Growth Drivers:
Rising Disposable Incomes in Emerging Markets and Growing Demand in Food & Beverage Industry

Challenges:
Fluctuations in Raw Material Prices

Restraints:
Emerging Alternative Technologies

Opportunities:
Technological Advancements in Enzyme Production and Increasing Demand for Bio-Based Products in Countries like India, China, and Brazil

Market Leaders and their expansionary development strategies
In March 2023, AB Enzymes acquired Shanghai Boai Bio, a leading Chinese producer of industrial enzymes, including glucoamylase, expanding its presence in the Asian market.
In January 2021, DUPONT launched SYNERXIA GEMSTONE collection of new high-performance yeasts. The new collection from the XCELIS platform includes SYNERXIA high-yield yeasts designed for the unique needs of ethanol producers. The product also expresses enough glucoamylase to displace up to 80 percent of the glucoamylase injected into fermentation. The yeast’s strong expression of the powerful glucoamylase offers reduced residual starch for many producers.


Key Target Audience
Manufacturer, Suppliers & Distributors, Research Organization, Potential Investors, Government Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Solid State Fermentation
  • Liquid State Fermentation
By Application
  • Dairy Products
  • Personal Care
  • Alcohol Production
  • Others
By Source
  • Microorganisms (Yeast, Fungi, Bacteria)
  • Plants (Rice, Wheat, Corn, Others)
  • Others

By End User
  • Pharmaceuticals & Healthcare
  • Food & Beverages
  • Textile
  • Paper
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Disposable Incomes in Emerging Markets
      • 3.2.2. Growing Demand in Food & Beverage Industry
    • 3.3. Market Challenges
      • 3.3.1. Fluctuations in Raw Material Prices
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Gluten-Free Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Glucoamylase, by Type, Application, Source, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Glucoamylase (Value)
      • 5.2.1. Global Glucoamylase by: Type (Value)
        • 5.2.1.1. Solid State Fermentation
        • 5.2.1.2. Liquid State Fermentation
      • 5.2.2. Global Glucoamylase by: Application (Value)
        • 5.2.2.1. Dairy Products
        • 5.2.2.2. Personal Care
        • 5.2.2.3. Alcohol Production
        • 5.2.2.4. Others
      • 5.2.3. Global Glucoamylase by: Source (Value)
        • 5.2.3.1. Microorganisms (Yeast, Fungi, Bacteria)
        • 5.2.3.2. Plants (Rice, Wheat, Corn, Others)
        • 5.2.3.3. Others
      • 5.2.4. Global Glucoamylase by: End User (Value)
        • 5.2.4.1. Pharmaceuticals & Healthcare
        • 5.2.4.2. Food & Beverages
        • 5.2.4.3. Textile
        • 5.2.4.4. Paper
        • 5.2.4.5. Others
      • 5.2.5. Global Glucoamylase Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Glucoamylase (Price)
      • 5.3.1. Global Glucoamylase by: Type (Price)
  • 6. Glucoamylase: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novozymes A/S (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. DuPont (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AB Enzymes (Denmark)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Kerry Group plc. (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cargill, Incorporated. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ADM (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tate & Lyle (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Südzucker AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roquette Frères (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio-Cat, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Glucoamylase Sale, by Type, Application, Source, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Glucoamylase (Value)
      • 7.2.1. Global Glucoamylase by: Type (Value)
        • 7.2.1.1. Solid State Fermentation
        • 7.2.1.2. Liquid State Fermentation
      • 7.2.2. Global Glucoamylase by: Application (Value)
        • 7.2.2.1. Dairy Products
        • 7.2.2.2. Personal Care
        • 7.2.2.3. Alcohol Production
        • 7.2.2.4. Others
      • 7.2.3. Global Glucoamylase by: Source (Value)
        • 7.2.3.1. Microorganisms (Yeast, Fungi, Bacteria)
        • 7.2.3.2. Plants (Rice, Wheat, Corn, Others)
        • 7.2.3.3. Others
      • 7.2.4. Global Glucoamylase by: End User (Value)
        • 7.2.4.1. Pharmaceuticals & Healthcare
        • 7.2.4.2. Food & Beverages
        • 7.2.4.3. Textile
        • 7.2.4.4. Paper
        • 7.2.4.5. Others
      • 7.2.5. Global Glucoamylase Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Glucoamylase (Price)
      • 7.3.1. Global Glucoamylase by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Glucoamylase: by Type(USD Million)
  • Table 2. Glucoamylase Solid State Fermentation , by Region USD Million (2018-2023)
  • Table 3. Glucoamylase Liquid State Fermentation , by Region USD Million (2018-2023)
  • Table 4. Glucoamylase: by Application(USD Million)
  • Table 5. Glucoamylase Dairy Products , by Region USD Million (2018-2023)
  • Table 6. Glucoamylase Personal Care , by Region USD Million (2018-2023)
  • Table 7. Glucoamylase Alcohol Production , by Region USD Million (2018-2023)
  • Table 8. Glucoamylase Others , by Region USD Million (2018-2023)
  • Table 9. Glucoamylase: by Source(USD Million)
  • Table 10. Glucoamylase Microorganisms (Yeast, Fungi, Bacteria) , by Region USD Million (2018-2023)
  • Table 11. Glucoamylase Plants (Rice, Wheat, Corn, Others) , by Region USD Million (2018-2023)
  • Table 12. Glucoamylase Others , by Region USD Million (2018-2023)
  • Table 13. Glucoamylase: by End User(USD Million)
  • Table 14. Glucoamylase Pharmaceuticals & Healthcare , by Region USD Million (2018-2023)
  • Table 15. Glucoamylase Food & Beverages , by Region USD Million (2018-2023)
  • Table 16. Glucoamylase Textile , by Region USD Million (2018-2023)
  • Table 17. Glucoamylase Paper , by Region USD Million (2018-2023)
  • Table 18. Glucoamylase Others , by Region USD Million (2018-2023)
  • Table 19. South America Glucoamylase, by Country USD Million (2018-2023)
  • Table 20. South America Glucoamylase, by Type USD Million (2018-2023)
  • Table 21. South America Glucoamylase, by Application USD Million (2018-2023)
  • Table 22. South America Glucoamylase, by Source USD Million (2018-2023)
  • Table 23. South America Glucoamylase, by End User USD Million (2018-2023)
  • Table 24. Brazil Glucoamylase, by Type USD Million (2018-2023)
  • Table 25. Brazil Glucoamylase, by Application USD Million (2018-2023)
  • Table 26. Brazil Glucoamylase, by Source USD Million (2018-2023)
  • Table 27. Brazil Glucoamylase, by End User USD Million (2018-2023)
  • Table 28. Argentina Glucoamylase, by Type USD Million (2018-2023)
  • Table 29. Argentina Glucoamylase, by Application USD Million (2018-2023)
  • Table 30. Argentina Glucoamylase, by Source USD Million (2018-2023)
  • Table 31. Argentina Glucoamylase, by End User USD Million (2018-2023)
  • Table 32. Rest of South America Glucoamylase, by Type USD Million (2018-2023)
  • Table 33. Rest of South America Glucoamylase, by Application USD Million (2018-2023)
  • Table 34. Rest of South America Glucoamylase, by Source USD Million (2018-2023)
  • Table 35. Rest of South America Glucoamylase, by End User USD Million (2018-2023)
  • Table 36. Asia Pacific Glucoamylase, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Glucoamylase, by Type USD Million (2018-2023)
  • Table 38. Asia Pacific Glucoamylase, by Application USD Million (2018-2023)
  • Table 39. Asia Pacific Glucoamylase, by Source USD Million (2018-2023)
  • Table 40. Asia Pacific Glucoamylase, by End User USD Million (2018-2023)
  • Table 41. China Glucoamylase, by Type USD Million (2018-2023)
  • Table 42. China Glucoamylase, by Application USD Million (2018-2023)
  • Table 43. China Glucoamylase, by Source USD Million (2018-2023)
  • Table 44. China Glucoamylase, by End User USD Million (2018-2023)
  • Table 45. Japan Glucoamylase, by Type USD Million (2018-2023)
  • Table 46. Japan Glucoamylase, by Application USD Million (2018-2023)
  • Table 47. Japan Glucoamylase, by Source USD Million (2018-2023)
  • Table 48. Japan Glucoamylase, by End User USD Million (2018-2023)
  • Table 49. India Glucoamylase, by Type USD Million (2018-2023)
  • Table 50. India Glucoamylase, by Application USD Million (2018-2023)
  • Table 51. India Glucoamylase, by Source USD Million (2018-2023)
  • Table 52. India Glucoamylase, by End User USD Million (2018-2023)
  • Table 53. South Korea Glucoamylase, by Type USD Million (2018-2023)
  • Table 54. South Korea Glucoamylase, by Application USD Million (2018-2023)
  • Table 55. South Korea Glucoamylase, by Source USD Million (2018-2023)
  • Table 56. South Korea Glucoamylase, by End User USD Million (2018-2023)
  • Table 57. Taiwan Glucoamylase, by Type USD Million (2018-2023)
  • Table 58. Taiwan Glucoamylase, by Application USD Million (2018-2023)
  • Table 59. Taiwan Glucoamylase, by Source USD Million (2018-2023)
  • Table 60. Taiwan Glucoamylase, by End User USD Million (2018-2023)
  • Table 61. Australia Glucoamylase, by Type USD Million (2018-2023)
  • Table 62. Australia Glucoamylase, by Application USD Million (2018-2023)
  • Table 63. Australia Glucoamylase, by Source USD Million (2018-2023)
  • Table 64. Australia Glucoamylase, by End User USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Glucoamylase, by Type USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Glucoamylase, by Application USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Glucoamylase, by Source USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Glucoamylase, by End User USD Million (2018-2023)
  • Table 69. Europe Glucoamylase, by Country USD Million (2018-2023)
  • Table 70. Europe Glucoamylase, by Type USD Million (2018-2023)
  • Table 71. Europe Glucoamylase, by Application USD Million (2018-2023)
  • Table 72. Europe Glucoamylase, by Source USD Million (2018-2023)
  • Table 73. Europe Glucoamylase, by End User USD Million (2018-2023)
  • Table 74. Germany Glucoamylase, by Type USD Million (2018-2023)
  • Table 75. Germany Glucoamylase, by Application USD Million (2018-2023)
  • Table 76. Germany Glucoamylase, by Source USD Million (2018-2023)
  • Table 77. Germany Glucoamylase, by End User USD Million (2018-2023)
  • Table 78. France Glucoamylase, by Type USD Million (2018-2023)
  • Table 79. France Glucoamylase, by Application USD Million (2018-2023)
  • Table 80. France Glucoamylase, by Source USD Million (2018-2023)
  • Table 81. France Glucoamylase, by End User USD Million (2018-2023)
  • Table 82. Italy Glucoamylase, by Type USD Million (2018-2023)
  • Table 83. Italy Glucoamylase, by Application USD Million (2018-2023)
  • Table 84. Italy Glucoamylase, by Source USD Million (2018-2023)
  • Table 85. Italy Glucoamylase, by End User USD Million (2018-2023)
  • Table 86. United Kingdom Glucoamylase, by Type USD Million (2018-2023)
  • Table 87. United Kingdom Glucoamylase, by Application USD Million (2018-2023)
  • Table 88. United Kingdom Glucoamylase, by Source USD Million (2018-2023)
  • Table 89. United Kingdom Glucoamylase, by End User USD Million (2018-2023)
  • Table 90. Netherlands Glucoamylase, by Type USD Million (2018-2023)
  • Table 91. Netherlands Glucoamylase, by Application USD Million (2018-2023)
  • Table 92. Netherlands Glucoamylase, by Source USD Million (2018-2023)
  • Table 93. Netherlands Glucoamylase, by End User USD Million (2018-2023)
  • Table 94. Rest of Europe Glucoamylase, by Type USD Million (2018-2023)
  • Table 95. Rest of Europe Glucoamylase, by Application USD Million (2018-2023)
  • Table 96. Rest of Europe Glucoamylase, by Source USD Million (2018-2023)
  • Table 97. Rest of Europe Glucoamylase, by End User USD Million (2018-2023)
  • Table 98. MEA Glucoamylase, by Country USD Million (2018-2023)
  • Table 99. MEA Glucoamylase, by Type USD Million (2018-2023)
  • Table 100. MEA Glucoamylase, by Application USD Million (2018-2023)
  • Table 101. MEA Glucoamylase, by Source USD Million (2018-2023)
  • Table 102. MEA Glucoamylase, by End User USD Million (2018-2023)
  • Table 103. Middle East Glucoamylase, by Type USD Million (2018-2023)
  • Table 104. Middle East Glucoamylase, by Application USD Million (2018-2023)
  • Table 105. Middle East Glucoamylase, by Source USD Million (2018-2023)
  • Table 106. Middle East Glucoamylase, by End User USD Million (2018-2023)
  • Table 107. Africa Glucoamylase, by Type USD Million (2018-2023)
  • Table 108. Africa Glucoamylase, by Application USD Million (2018-2023)
  • Table 109. Africa Glucoamylase, by Source USD Million (2018-2023)
  • Table 110. Africa Glucoamylase, by End User USD Million (2018-2023)
  • Table 111. North America Glucoamylase, by Country USD Million (2018-2023)
  • Table 112. North America Glucoamylase, by Type USD Million (2018-2023)
  • Table 113. North America Glucoamylase, by Application USD Million (2018-2023)
  • Table 114. North America Glucoamylase, by Source USD Million (2018-2023)
  • Table 115. North America Glucoamylase, by End User USD Million (2018-2023)
  • Table 116. United States Glucoamylase, by Type USD Million (2018-2023)
  • Table 117. United States Glucoamylase, by Application USD Million (2018-2023)
  • Table 118. United States Glucoamylase, by Source USD Million (2018-2023)
  • Table 119. United States Glucoamylase, by End User USD Million (2018-2023)
  • Table 120. Canada Glucoamylase, by Type USD Million (2018-2023)
  • Table 121. Canada Glucoamylase, by Application USD Million (2018-2023)
  • Table 122. Canada Glucoamylase, by Source USD Million (2018-2023)
  • Table 123. Canada Glucoamylase, by End User USD Million (2018-2023)
  • Table 124. Mexico Glucoamylase, by Type USD Million (2018-2023)
  • Table 125. Mexico Glucoamylase, by Application USD Million (2018-2023)
  • Table 126. Mexico Glucoamylase, by Source USD Million (2018-2023)
  • Table 127. Mexico Glucoamylase, by End User USD Million (2018-2023)
  • Table 128. Glucoamylase: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Glucoamylase: by Type(USD Million)
  • Table 140. Glucoamylase Solid State Fermentation , by Region USD Million (2025-2030)
  • Table 141. Glucoamylase Liquid State Fermentation , by Region USD Million (2025-2030)
  • Table 142. Glucoamylase: by Application(USD Million)
  • Table 143. Glucoamylase Dairy Products , by Region USD Million (2025-2030)
  • Table 144. Glucoamylase Personal Care , by Region USD Million (2025-2030)
  • Table 145. Glucoamylase Alcohol Production , by Region USD Million (2025-2030)
  • Table 146. Glucoamylase Others , by Region USD Million (2025-2030)
  • Table 147. Glucoamylase: by Source(USD Million)
  • Table 148. Glucoamylase Microorganisms (Yeast, Fungi, Bacteria) , by Region USD Million (2025-2030)
  • Table 149. Glucoamylase Plants (Rice, Wheat, Corn, Others) , by Region USD Million (2025-2030)
  • Table 150. Glucoamylase Others , by Region USD Million (2025-2030)
  • Table 151. Glucoamylase: by End User(USD Million)
  • Table 152. Glucoamylase Pharmaceuticals & Healthcare , by Region USD Million (2025-2030)
  • Table 153. Glucoamylase Food & Beverages , by Region USD Million (2025-2030)
  • Table 154. Glucoamylase Textile , by Region USD Million (2025-2030)
  • Table 155. Glucoamylase Paper , by Region USD Million (2025-2030)
  • Table 156. Glucoamylase Others , by Region USD Million (2025-2030)
  • Table 157. South America Glucoamylase, by Country USD Million (2025-2030)
  • Table 158. South America Glucoamylase, by Type USD Million (2025-2030)
  • Table 159. South America Glucoamylase, by Application USD Million (2025-2030)
  • Table 160. South America Glucoamylase, by Source USD Million (2025-2030)
  • Table 161. South America Glucoamylase, by End User USD Million (2025-2030)
  • Table 162. Brazil Glucoamylase, by Type USD Million (2025-2030)
  • Table 163. Brazil Glucoamylase, by Application USD Million (2025-2030)
  • Table 164. Brazil Glucoamylase, by Source USD Million (2025-2030)
  • Table 165. Brazil Glucoamylase, by End User USD Million (2025-2030)
  • Table 166. Argentina Glucoamylase, by Type USD Million (2025-2030)
  • Table 167. Argentina Glucoamylase, by Application USD Million (2025-2030)
  • Table 168. Argentina Glucoamylase, by Source USD Million (2025-2030)
  • Table 169. Argentina Glucoamylase, by End User USD Million (2025-2030)
  • Table 170. Rest of South America Glucoamylase, by Type USD Million (2025-2030)
  • Table 171. Rest of South America Glucoamylase, by Application USD Million (2025-2030)
  • Table 172. Rest of South America Glucoamylase, by Source USD Million (2025-2030)
  • Table 173. Rest of South America Glucoamylase, by End User USD Million (2025-2030)
  • Table 174. Asia Pacific Glucoamylase, by Country USD Million (2025-2030)
  • Table 175. Asia Pacific Glucoamylase, by Type USD Million (2025-2030)
  • Table 176. Asia Pacific Glucoamylase, by Application USD Million (2025-2030)
  • Table 177. Asia Pacific Glucoamylase, by Source USD Million (2025-2030)
  • Table 178. Asia Pacific Glucoamylase, by End User USD Million (2025-2030)
  • Table 179. China Glucoamylase, by Type USD Million (2025-2030)
  • Table 180. China Glucoamylase, by Application USD Million (2025-2030)
  • Table 181. China Glucoamylase, by Source USD Million (2025-2030)
  • Table 182. China Glucoamylase, by End User USD Million (2025-2030)
  • Table 183. Japan Glucoamylase, by Type USD Million (2025-2030)
  • Table 184. Japan Glucoamylase, by Application USD Million (2025-2030)
  • Table 185. Japan Glucoamylase, by Source USD Million (2025-2030)
  • Table 186. Japan Glucoamylase, by End User USD Million (2025-2030)
  • Table 187. India Glucoamylase, by Type USD Million (2025-2030)
  • Table 188. India Glucoamylase, by Application USD Million (2025-2030)
  • Table 189. India Glucoamylase, by Source USD Million (2025-2030)
  • Table 190. India Glucoamylase, by End User USD Million (2025-2030)
  • Table 191. South Korea Glucoamylase, by Type USD Million (2025-2030)
  • Table 192. South Korea Glucoamylase, by Application USD Million (2025-2030)
  • Table 193. South Korea Glucoamylase, by Source USD Million (2025-2030)
  • Table 194. South Korea Glucoamylase, by End User USD Million (2025-2030)
  • Table 195. Taiwan Glucoamylase, by Type USD Million (2025-2030)
  • Table 196. Taiwan Glucoamylase, by Application USD Million (2025-2030)
  • Table 197. Taiwan Glucoamylase, by Source USD Million (2025-2030)
  • Table 198. Taiwan Glucoamylase, by End User USD Million (2025-2030)
  • Table 199. Australia Glucoamylase, by Type USD Million (2025-2030)
  • Table 200. Australia Glucoamylase, by Application USD Million (2025-2030)
  • Table 201. Australia Glucoamylase, by Source USD Million (2025-2030)
  • Table 202. Australia Glucoamylase, by End User USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Glucoamylase, by Type USD Million (2025-2030)
  • Table 204. Rest of Asia-Pacific Glucoamylase, by Application USD Million (2025-2030)
  • Table 205. Rest of Asia-Pacific Glucoamylase, by Source USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Glucoamylase, by End User USD Million (2025-2030)
  • Table 207. Europe Glucoamylase, by Country USD Million (2025-2030)
  • Table 208. Europe Glucoamylase, by Type USD Million (2025-2030)
  • Table 209. Europe Glucoamylase, by Application USD Million (2025-2030)
  • Table 210. Europe Glucoamylase, by Source USD Million (2025-2030)
  • Table 211. Europe Glucoamylase, by End User USD Million (2025-2030)
  • Table 212. Germany Glucoamylase, by Type USD Million (2025-2030)
  • Table 213. Germany Glucoamylase, by Application USD Million (2025-2030)
  • Table 214. Germany Glucoamylase, by Source USD Million (2025-2030)
  • Table 215. Germany Glucoamylase, by End User USD Million (2025-2030)
  • Table 216. France Glucoamylase, by Type USD Million (2025-2030)
  • Table 217. France Glucoamylase, by Application USD Million (2025-2030)
  • Table 218. France Glucoamylase, by Source USD Million (2025-2030)
  • Table 219. France Glucoamylase, by End User USD Million (2025-2030)
  • Table 220. Italy Glucoamylase, by Type USD Million (2025-2030)
  • Table 221. Italy Glucoamylase, by Application USD Million (2025-2030)
  • Table 222. Italy Glucoamylase, by Source USD Million (2025-2030)
  • Table 223. Italy Glucoamylase, by End User USD Million (2025-2030)
  • Table 224. United Kingdom Glucoamylase, by Type USD Million (2025-2030)
  • Table 225. United Kingdom Glucoamylase, by Application USD Million (2025-2030)
  • Table 226. United Kingdom Glucoamylase, by Source USD Million (2025-2030)
  • Table 227. United Kingdom Glucoamylase, by End User USD Million (2025-2030)
  • Table 228. Netherlands Glucoamylase, by Type USD Million (2025-2030)
  • Table 229. Netherlands Glucoamylase, by Application USD Million (2025-2030)
  • Table 230. Netherlands Glucoamylase, by Source USD Million (2025-2030)
  • Table 231. Netherlands Glucoamylase, by End User USD Million (2025-2030)
  • Table 232. Rest of Europe Glucoamylase, by Type USD Million (2025-2030)
  • Table 233. Rest of Europe Glucoamylase, by Application USD Million (2025-2030)
  • Table 234. Rest of Europe Glucoamylase, by Source USD Million (2025-2030)
  • Table 235. Rest of Europe Glucoamylase, by End User USD Million (2025-2030)
  • Table 236. MEA Glucoamylase, by Country USD Million (2025-2030)
  • Table 237. MEA Glucoamylase, by Type USD Million (2025-2030)
  • Table 238. MEA Glucoamylase, by Application USD Million (2025-2030)
  • Table 239. MEA Glucoamylase, by Source USD Million (2025-2030)
  • Table 240. MEA Glucoamylase, by End User USD Million (2025-2030)
  • Table 241. Middle East Glucoamylase, by Type USD Million (2025-2030)
  • Table 242. Middle East Glucoamylase, by Application USD Million (2025-2030)
  • Table 243. Middle East Glucoamylase, by Source USD Million (2025-2030)
  • Table 244. Middle East Glucoamylase, by End User USD Million (2025-2030)
  • Table 245. Africa Glucoamylase, by Type USD Million (2025-2030)
  • Table 246. Africa Glucoamylase, by Application USD Million (2025-2030)
  • Table 247. Africa Glucoamylase, by Source USD Million (2025-2030)
  • Table 248. Africa Glucoamylase, by End User USD Million (2025-2030)
  • Table 249. North America Glucoamylase, by Country USD Million (2025-2030)
  • Table 250. North America Glucoamylase, by Type USD Million (2025-2030)
  • Table 251. North America Glucoamylase, by Application USD Million (2025-2030)
  • Table 252. North America Glucoamylase, by Source USD Million (2025-2030)
  • Table 253. North America Glucoamylase, by End User USD Million (2025-2030)
  • Table 254. United States Glucoamylase, by Type USD Million (2025-2030)
  • Table 255. United States Glucoamylase, by Application USD Million (2025-2030)
  • Table 256. United States Glucoamylase, by Source USD Million (2025-2030)
  • Table 257. United States Glucoamylase, by End User USD Million (2025-2030)
  • Table 258. Canada Glucoamylase, by Type USD Million (2025-2030)
  • Table 259. Canada Glucoamylase, by Application USD Million (2025-2030)
  • Table 260. Canada Glucoamylase, by Source USD Million (2025-2030)
  • Table 261. Canada Glucoamylase, by End User USD Million (2025-2030)
  • Table 262. Mexico Glucoamylase, by Type USD Million (2025-2030)
  • Table 263. Mexico Glucoamylase, by Application USD Million (2025-2030)
  • Table 264. Mexico Glucoamylase, by Source USD Million (2025-2030)
  • Table 265. Mexico Glucoamylase, by End User USD Million (2025-2030)
  • Table 266. Glucoamylase: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Glucoamylase: by Type USD Million (2018-2023)
  • Figure 5. Global Glucoamylase: by Application USD Million (2018-2023)
  • Figure 6. Global Glucoamylase: by Source USD Million (2018-2023)
  • Figure 7. Global Glucoamylase: by End User USD Million (2018-2023)
  • Figure 8. South America Glucoamylase Share (%), by Country
  • Figure 9. Asia Pacific Glucoamylase Share (%), by Country
  • Figure 10. Europe Glucoamylase Share (%), by Country
  • Figure 11. MEA Glucoamylase Share (%), by Country
  • Figure 12. North America Glucoamylase Share (%), by Country
  • Figure 13. Global Glucoamylase: by Type USD/Units (2018-2023)
  • Figure 14. Global Glucoamylase share by Players 2023 (%)
  • Figure 15. Global Glucoamylase share by Players (Top 3) 2023(%)
  • Figure 16. Global Glucoamylase share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Novozymes A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 19. Novozymes A/S (Denmark) Revenue: by Geography 2023
  • Figure 20. DuPont (United States) Revenue, Net Income and Gross profit
  • Figure 21. DuPont (United States) Revenue: by Geography 2023
  • Figure 22. AB Enzymes (Denmark) Revenue, Net Income and Gross profit
  • Figure 23. AB Enzymes (Denmark) Revenue: by Geography 2023
  • Figure 24. Kerry Group plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Kerry Group plc. (Ireland) Revenue: by Geography 2023
  • Figure 26. Cargill, Incorporated. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cargill, Incorporated. (United States) Revenue: by Geography 2023
  • Figure 28. ADM (United States) Revenue, Net Income and Gross profit
  • Figure 29. ADM (United States) Revenue: by Geography 2023
  • Figure 30. Tate & Lyle (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Tate & Lyle (United Kingdom) Revenue: by Geography 2023
  • Figure 32. Südzucker AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Südzucker AG (Germany) Revenue: by Geography 2023
  • Figure 34. Roquette Frères (France) Revenue, Net Income and Gross profit
  • Figure 35. Roquette Frères (France) Revenue: by Geography 2023
  • Figure 36. Bio-Cat, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Bio-Cat, Inc. (United States) Revenue: by Geography 2023
  • Figure 38. Global Glucoamylase: by Type USD Million (2025-2030)
  • Figure 39. Global Glucoamylase: by Application USD Million (2025-2030)
  • Figure 40. Global Glucoamylase: by Source USD Million (2025-2030)
  • Figure 41. Global Glucoamylase: by End User USD Million (2025-2030)
  • Figure 42. South America Glucoamylase Share (%), by Country
  • Figure 43. Asia Pacific Glucoamylase Share (%), by Country
  • Figure 44. Europe Glucoamylase Share (%), by Country
  • Figure 45. MEA Glucoamylase Share (%), by Country
  • Figure 46. North America Glucoamylase Share (%), by Country
  • Figure 47. Global Glucoamylase: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Novozymes A/S (Denmark)
  • DuPont (United States)
  • AB Enzymes (Denmark)
  • Kerry Group plc. (Ireland)
  • Cargill, Incorporated. (United States)
  • ADM (United States)
  • Tate & Lyle (United Kingdom)
  • Südzucker AG (Germany)
  • Roquette Frères (France)
  • Bio-Cat, Inc. (United States)
Additional players considered in the study are as follows:
Guangxi Jinyuan Biochemical Group Co., Ltd. (China) , VTR BIOTECH PTY LIMITED (Austria) , DSM (Netherlands) , Wuhan Sunhy Biology Co., Ltd. (China) , Beijing Challenge International Trade Co., Ltd. (China)
Select User Access Type

Key Highlights of Report


Feb 2024 229 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Glucoamylase Quantitative research analysis
Global Glucoamylase Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Novozymes A/S (Denmark), DuPont (United States), AB Enzymes (Denmark), Kerry Group plc. (Ireland), Cargill, Incorporated. (United States), ADM (United States), Tate & Lyle (United Kingdom), Südzucker AG (Germany), Roquette Frères (France) and Bio-Cat, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Demand for Gluten-Free Products" is seen as one of major influencing trends for Glucoamylase Market during projected period 2023-2030.
The Glucoamylase market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Glucoamylase Report?

Have a Query? Click Here

Other Related Reports

Epigenetics Drugs Comprehensive Study by Application (Solid Tumors, Liquid Tumors, Inflammatory Diseases, Metabolic Diseases, Infectious Diseases, Cardiovascular Diseases), Mechanism of Action (DNMT ...
$ 3450
Urinalysis Test Comprehensive Study by Type (Dipstick Test, Visual Exam, Microscopic Exam), Indication (Urinary Tract Infection, Kidney Stones, Diabetes, Others), Technology (Fully Automated, Semi-au...
$ 3800
Medical Dispatch Solution Comprehensive Study by Application (Hospital, Clinic, Research Institutes, Others), Software (Web-Based, On-premise), Components (Solutions, Services) Players and Region - ...
$ 3800
Neurodegenerative Drugs Comprehensive Study by Route of Administration (Oral, Injection, Transdermal, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), Indication ...
$ 3800
Online Dietary Supplement Comprehensive Study by Type (Vitamins, Minerals, Herbal Products, Amino acids, Botanicals, Sports Nutrition), Application (Pharmaceuticals, Hospitals, Households), Forms (Dr...
$ 3800
Interventional Oncology Comprehensive Study by Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, Other), Procedure Type (Ablation (Thermal Tumor Ablation, Non-Thermal Tumor Ablation ), Radiation...
$ 3350